Skip to main content
PMC home page
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1967 Jun;30(2):400–416. doi: 10.1111/j.1476-5381.1967.tb02147.x

A comparison of the effects of chlorpromazine and some related phenothiazines in reducing the rigidity of the decerebrate cat and in some other central actions.

E M Keary, D R Maxwell
PMCID: PMC1557266  PMID: 6036418

Full text

PDF
400

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AHMED A., MARSHALL P. B. Relationship between anti-acetylcholine and anti-Tremorine activity in anti-parkinsonian and related drugs. Br J Pharmacol Chemother. 1962 Apr;18:247–254. doi: 10.1111/j.1476-5381.1962.tb01405.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BASMAJIAN J. V., SZATMARI A. Effect of largactil (chlorpromazine) on human spasticity and electromyogram; preliminary report. AMA Arch Neurol Psychiatry. 1955 Feb;73(2):224–231. doi: 10.1001/archneurpsyc.1955.02330080102019. [DOI] [PubMed] [Google Scholar]
  3. BUSCH G., HENATSCH H. D., SCHULTE F. J. [Electrophysiological studies on the effects of neuroleptic and tranquilizing substances (phenothiazine, meprobamate) on the spinal motor system]. Arzneimittelforschung. 1960 Apr;10:217–223. [PubMed] [Google Scholar]
  4. CHIN J. H., SMITH C. M. Effects of some central nervous system depressants on the phasic and tonic stretch reflex. J Pharmacol Exp Ther. 1962 Jun;136:276–283. [PubMed] [Google Scholar]
  5. COURVOISIER S., DUCROT R., FOURNEL J., JULOU L. Propriétés pharmacodvnamiques générales de la lévomépromazine (7.044 R.P.). C R Seances Soc Biol Fil. 1957;151(7):1378–1382. [PubMed] [Google Scholar]
  6. COURVOISIER S., DUCROT R., FOURNEL J., JULOU L. Propriétés pharmacologiques générales d'un nouveau dérivé de la phénothiazine, neuroleptique puissant a action neurovégétative discrète, le chlorhydrate de (méthyl-2' diméthyl-amino-3' propyl-1')-10 phénothiazine (6.549 R.P.). Arch Int Pharmacodyn Ther. 1958 May 1;115(1-2):90–113. [PubMed] [Google Scholar]
  7. DASGUPTA S. R., WERNER G. Inhibitory actions of chlorpormazine on motor activity. Arch Int Pharmacodyn Ther. 1955 Jan 1;100(3-4):409–417. [PubMed] [Google Scholar]
  8. ELDRED E., GRANIT R., MERTON P. A. Supraspinal control of the muscle spindles and its significance. J Physiol. 1953 Dec 29;122(3):498–523. doi: 10.1113/jphysiol.1953.sp005017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. GRANIT R., HOLMGREN B., MERTON P. A. The two routes for excitation of muscle and their subservience to the cerebellum. J Physiol. 1955 Oct 28;130(1):213–224. doi: 10.1113/jphysiol.1955.sp005404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. HENATSCH H. D., INGVAR D. H. Chlorpromazin und Spastizität; eine experimentelle elektrophysiologische Untersuchung. Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr. 1956;195(1):77–93. doi: 10.1007/BF00342008. [DOI] [PubMed] [Google Scholar]
  11. Hudson R. D. Effects of chlorpromazine on spinal cord reflex mechanisms. Int J Neuropharmacol. 1966 Jan;5(1):43–58. doi: 10.1016/0028-3908(66)90050-5. [DOI] [PubMed] [Google Scholar]
  12. JULOU L., COURVOISIER S., DUCROT R., FOURNEL J., BARDONE M. C., LEAU O., MYON J. ETUDE DES PROPRI'ET'ES PHARMACOLOGIQUES G'EN'ERALES DE LA CYANO-3. C R Seances Soc Biol Fil. 1963 Nov 15;157:1242–1247. [PubMed] [Google Scholar]
  13. LAURENCE D. R., WEBSTER R. A. Tachyphylaxis to the antitetanus activity of some phenothiazine compounds. Br J Pharmacol Chemother. 1961 Jun;16:296–308. doi: 10.1111/j.1476-5381.1961.tb01088.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. LESLIE G. B., MAXWELL D. R. SOME PHARMACOLOGICAL PROPERTIES OF THIOPROPERAZINE AND THEIR MODIFICATION BY ANTI-PARKINSONIAN DRUGS. Br J Pharmacol Chemother. 1964 Apr;22:301–317. doi: 10.1111/j.1476-5381.1964.tb02035.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Matthews W. B. The action of chlorproethazine on spasticity. Brain. 1965 Dec;88(5):1057–1064. doi: 10.1093/brain/88.5.1057. [DOI] [PubMed] [Google Scholar]
  16. PRESTON J. B. Effects of chlorpromazine on the central nervous system of the cat: a possible neural basis for action. J Pharmacol Exp Ther. 1956 Sep;118(1):100–115. [PubMed] [Google Scholar]
  17. RANDALL L. O. Pharmacology of methaminodiazepoxide. Dis Nerv Syst. 1960 Mar;21(3):7–10. [PubMed] [Google Scholar]
  18. RUSHWORTH G. THE NATURE AND MANAGEMENT OF SPASTICITY. THE PATHOPHYSIOLOGY OF SPASTICITY. Proc R Soc Med. 1964 Aug;57:715–720. [PMC free article] [PubMed] [Google Scholar]
  19. SIGWALD J., BOUTTIER D., RAYMONDEAUD C. [Chlorproethazine. Its importance in neurology]. Presse Med. 1961 Nov 18;69:2187–2189. [PubMed] [Google Scholar]
  20. SILVESTRINI B., MAFFII G. Effects of chlorpromazine, promazine, diethazine, reserpine, hydroxyzine, and morphine upon some mono- and polysynaptic motor reflexes. J Pharm Pharmacol. 1959 Apr;11(4):224–233. doi: 10.1111/j.2042-7158.1959.tb12548.x. [DOI] [PubMed] [Google Scholar]
  21. Schweitzer A., Wright S. Effects on the knee jerk of stimulation of the central end of the vagus and of various changes in the circulation and respiration. J Physiol. 1937 Jan 18;88(4):459–475. doi: 10.1113/jphysiol.1937.sp003453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. WEBSTER R. A. Centrally acting muscle relaxants in tetanus. Br J Pharmacol Chemother. 1961 Dec;17:507–518. doi: 10.1111/j.1476-5381.1961.tb01137.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. WITKIN L. B., SPITALETTA P., PLUMMER A. J. Effects of some central depressants on two simple reflexes in the mouse. J Pharmacol Exp Ther. 1959 Aug;126:330–333. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES